TVTX
Travere Therapeutics Inc.
$26.20
+$1.04(+4.13%)
59
Overall
--
Value
63
Tech
55
Quality
Market Cap
$2.27B
Volume
1.55M
52W Range
$12.91 - $28.69
Target Price
$35.93
EPS Estimates Overview
| Current Quarter | $-0.31 | Next Quarter | $-0.27 |
| Current Year | $-1.17 | Next Year | $-0.02 |
| QoQ Growth | +12.9% | YoY Growth | +98.3% |
| 3Y EPS CAGR | -10.7% | Target Price | $35.93 |
| Consensus | Buy | Upside | +37.1% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TVTX | $26.20 | +4.1% | 1.55M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Travere Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW